# Uncommon Extrapyramidal Reaction to Ondansetron

**Authors:** Carolina S Dias, Catarina Moreira, João Gaspar, Maria Santos

PMC · DOI: 10.7759/cureus.80362 · Cureus · 2025-03-10

## TL;DR

An elderly cancer patient experienced neurological symptoms linked to ondansetron, mimicking a stroke, highlighting the need for careful medication review.

## Contribution

This case report highlights an uncommon extrapyramidal reaction to ondansetron mimicking cerebrovascular events.

## Key findings

- Neurological symptoms occurred after ondansetron administration and resolved with biperiden.
- Symptoms mimicked cerebrovascular events but were later attributed to an adverse drug reaction.
- Discontinuation of ondansetron and correction of hyponatremia prevented further episodes.

## Abstract

We describe the case of a 77-year-old man, who was admitted for the initiation of chemotherapy for stage IV small cell lung cancer without cerebral metastases. On the first day post-admission, the patient developed altered mental status and right-sided weakness after premedication with ondansetron and dexamethasone. Symptoms resolved spontaneously within 90 minutes. An ischemic event was suspected despite unremarkable brain imaging. Prophylactic anticoagulation and statins were initiated.

Five days later, a second episode of altered mental status, anisocoria, facial paresis, and severe dysarthria occurred following ondansetron administration. Bloodwork revealed significant hyponatremia (116 mEq/L), suggesting Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), despite this suspicion, there was no further investigation to confirm this diagnosis due to rapid symptom reversal after biperiden administration, implicating an adverse reaction to ondansetron.

Ondansetron and metoclopramide were discontinued, hyponatremia was corrected, and no further episodes occurred during the hospital stay. This case highlights the necessity of awareness for adverse reactions of ondansetron that can mimic cerebrovascular events and the need for a thorough revision of medication in complex cases.

## Linked entities

- **Chemicals:** ondansetron (PubChem CID 4595), dexamethasone (PubChem CID 5743), biperiden (PubChem CID 2381)
- **Diseases:** small cell lung cancer (MONDO:0008433)

## Full-text entities

- **Diseases:** ischemic (MESH:D002545), cerebral metastases (MESH:D009362), cerebrovascular events (MESH:D002561), facial paresis (MESH:D005158), weakness (MESH:D018908), SIADH (MESH:D007177), anisocoria (MESH:D015875), Extrapyramidal (MESH:D001480), hyponatremia (MESH:D007010), stage IV small cell lung cancer (MESH:D055752), dysarthria (MESH:D004401)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11981680/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11981680/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC11981680/full.md

---
Source: https://tomesphere.com/paper/PMC11981680